节点文献
平阳霉素瘤体内注射治疗小儿体表血管瘤的临床研究
Clinical Study of Intratumoral Pingyangmycin Injection for Hemangiomas in Children
【摘要】 目的:探讨采用平阳霉素行小儿体表血管瘤注射的临床疗效及安全性。方法:将平阳霉素配为1%浓度,用带第4号针头注射器吸取适量药液,根据血管瘤大小直接注射至瘤体内,直至瘤体表面发白肿胀为止。每1~2周注射一次,每次量不超过6mg。结果:182例患者经平阳霉素注射治疗后,随访3个月到1年。治愈率49.5%、显效率38.5%、总有效率88%。除部分患儿注射局部肿痛外,全身不良反应轻微。结论:平阳霉素瘤体内注射治疗小儿体表血管瘤疗效确切,副作用小、安全可靠。
【Abstract】 Objectives: To observe the efficacy of pinyanmycin injection for superficial hemangiomas in children.Methods: Pingyangmycin was intratumorally injected to the hemangioma mass at the concentration of 1% until the mass had become pale and swollen once two weeks for 3~5 times.Results: 182 children received pingyangmycin injection and were followed for 3 months to 1 year.The cure rate was was 49.5%,and the effectiveness rate was 38.5%.Therefore,the total effectiveness rate was 88%.The complication was minimal.Conclusions: Intratumoral injection of pingyangmycin was a safe,convenient and effective therapeutic modality for superficial hemangioma in children.
- 【文献出处】 河北医学 ,Hebei Medicine , 编辑部邮箱 ,2006年01期
- 【分类号】R732.2
- 【被引频次】3
- 【下载频次】76